Browsing by Author APOSTOLIDIS Christos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 67 to 86 of 120 < previous   next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2004JRC29295MUC1 Expression in Primary and Metastatic Pancreatic Cancer Cells for in vitro Treatment by 213Bi-C595 RadioimmunoconjugateQU Chang f.; LI Yong; SONG Yang j.; RIZVI S.m.a.; RAJA Chand; ZHANG D.; SAMRA J.; SMITH R.; PERKINS A.c.; APOSTOLIDIS Christos, et alArticles in Journals
2012JRC71641Non-aqueous Synthesis of Isotropic and Anisotropic Actinide Oxide NanocrystalsHUDRY DAMIEN; APOSTOLIDIS Christos; WALTER OLAF; GOUDER Thomas; COURTOIS Eglantine; KUEBEL Christian; MEYER D.Articles in Journals
2012JRC70139Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostateRIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a.Articles in Journals
1996JRC12649Oxo-Bridged Bimetallic Organouranium Complexes. The Crystal Structure of nu-Oxo-Bis[Tris(Cyclopentadienyl)Uranium]SPIRLET M.r.; REBIZANT Jean; APOSTOLIDIS Christos; DORNBERGER Ernst; POWIETZKA B.Articles in Journals
2014JRC89699A plutonium-based single-molecule magnetMAGNANI Nicola; COLINEAU Eric; GRIVEAU Jean-Christophe; APOSTOLIDIS Christos; WALTER OLAF; CACIUFFO RobertoArticles in Journals
2008JRC48531Preparation and Testing of Bevacizumab Radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206RIZVI S.; SONG E.; RAJA C.; BERETOV J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; RUSSELL P. J.; KEARSLEY J.; ABBAS Kamel; ALLEN B. J.Articles in Journals
2008JRC48532Production of 230U/226Th for Targeted Alpha Therapy via Proton Irradiation of 231PaMORGENSTERN Alfred; LEBEDA O.; STURSA J.; BRUCHERTSEIFER Frank; CAPOTE R.; MCGINLEY John; RASMUSSEN Gert; SIN M.; ZIELINSKA B.; APOSTOLIDIS ChristosArticles in Journals
1998JRC16826Production of Ac-225 and Application of the Bi-213 Daughter in Cancer Therapy.KOCH Lothar; APOSTOLIDIS Christos; JANSSENS Willem; VAN GEEL Jacobus; MOLINET RogerContributions to Conferences
2008JRC48527Production of Alpha Emitters for Targeted Alpha TherapyMORGENSTERN Alfred; ABBAS Kamel; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2008JRC48835Production of Alpha Emitting Radionuclides for Nuclear MedicineMORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankArticles in books
2001JRC21321Production of Carrier Free Actinium-225/Bismuth-212 from Thorium-229 for alpha-Immunitherapy.APOSTOLIDIS Christos; BETTI Maria; CARLOS-MARQUEZ R.; JANSSENS Willem; MOLINET Roger; NIKULA T.; QUADI AliContributions to Conferences
2009JRC53299Radioimmunotherapy of Breast Cancer Metastases with Alpha-Particle-emitter 225Ac: Comparing Efficacy with 213Bi, 90YSONG Hong; HOBBS Robert F.; VAJRAVELU Ravy; HUSO David L.; ESAIAS Caroline; APOSTOLIDIS Christos; MORGENSTERN Alfred; SGOUROS GeorgeArticles in Journals
2009JRC55683Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAbPFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2001JRC21192Radiopeptide Therapy with Cholecystokinin(CCK)-B/Gastrin Receptor Ligands Labeled with Auger/Conversion Electron-versus alpha- or Conventional beta Emitters.BEHR T.m.; BEHE M.; ANGERSTEIN C.; STABIN M.g.; APOSTOLIDIS Christos; MOLINET Roger; KOCH Lothar; ROESCH F.; BECKER W.Contributions to Conferences
2000JRC19822Radiopeptide Therapy with Cholecystokinin-B/Gastrin Receptor Ligands: Dose-Limiting Toxicity and Therapeutic Efficacy of Auger / Conversion Electron (111-In, 140-Nd) vs alpha(213-Bi) or Conventional beta(90-Y, 153-Sm) Emitters.BEHR T.m.; BEBE M.; STABIN M.g.; ANGERSTEIN C.; MACH R.; HAGEMANN L.; APOSTOLIDIS Christos; MOLINET Roger; KOCH Lothar; ROESCH F., et alContributions to Conferences
2012JRC69267Reduction of Pu(VI) by FeCARBOL Paul; WEGEN Detlef; WISS Thierry; JANSSEN ARNE; NICHOLL Adrian; CREMER Bert; MALMBECK Rikard; VAN WINCKEL Stefaan; APOSTOLIDIS Christos; ALVAREZ SARANDES LAVANDERA Rafael, et alContributions to Conferences
2001JRC20857Separation of 248Cm from a 252Cf Neutron Source for Production of Cm Targets.MALMBECK R.; APOSTOLIDIS Christos; CARLOS R.; GLATZ Jean paul; MOLINET Roger; MORGENSTERN A.; NICHOLL Adrian felim; PAGLIOSA G.; ROEMER K.; SCHAEDEL M., et alArticles in Journals
2004JRC28555Sequential Therapy with Cytarabine and Bismuth-213 (213BI)-Labeled-HuM195(Anit-CD33) for Acute Myeloid Leukemia (AML).MULFORD D.a.; PANDIT-TASKAR N.; MC DEVITT M.r.; FINN R.d.; APOSTOLIDIS Christos; MORGENSTERN A.; DIVGI C.r.; LARSON S.m.; SCHEINBERG D.a.; JURCIC J.g.Contributions to Conferences
2002JRC21741Single-Column Extraction Chromatographic Separation of U, Np, Pu and Am.MORGENSTERN A.; APOSTOLIDIS Christos; CARLOS-MARQUEZ R.; MAYER Klaus; MOLINET RogerArticles in Journals
2009JRC54280Spectroscopic Study of the Interaction of U(VI) with Transferrin and Albumin for Speciation of U(VI) under Blood Serum ConditionsMONTAVON Gilles; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; REPINC Urska; MORGENSTERN AlfredArticles in Journals